Explore 3 Stock Ideas & Industry Insights Download Free Report

News

U.S. Markets Daily Wrap: Fed in Focus Amid Geopolitical Tensions and Mixed Economic Signals

Index Update:U.S. markets remained cautious as investors awaited the Federal Reserve’s policy decision, with focus on future guidance amid tariff uncertainties and escalating geopolitical tensions. All major indexes closed lower in the prior session, with the Dow Jones down 0.7%, the S&P 500 falling …

Team Kalkine | 18 June 2025

Royal Bank of Canada Downgrades Axsome Therapeutics (NASDAQ: AXSM)

Axsome Therapeutics Inc. (NASDAQ: AXSM) experienced a slight drop in its share price this week, following a downgrade by Royal Bank of Canada. The firm adjusted its rating fromOutperformtoMarket Perform, citing a reassessment of valuation metrics and future growth assumptions.

Team Kalkine | 18 June 2025

JPMorgan Upgrades Zscaler (NASDAQ:ZS) to Overweight Amid Market Dip

Zscaler Inc. (NASDAQ: ZS), a cybersecurity-focused technology firm, saw its stock edge up by 0.8% to USD307.31 following an analyst upgrade by JPMorgan Chase & Co. The investment bank raised its rating on the stock toOverweight, reflecting a shift in its assessment of the …

Team Kalkine | 18 June 2025

SideChannel (OTCQB: SDCH) Expands DoD Presence with Second Enclave Deployment

SideChannel, Inc. (OTCQB: SDCH), a U.S.-based cybersecurity services and software provider, announced the deployment of its Enclave zero-trust security solution within a second branch of the United States Department of Defense (DoD). This deployment, facilitated through one of the company’s federal resale partners, extends …

Team Kalkine | 18 June 2025

OptimizeRx (Nasdaq: OPRX) Partners with Simulmedia for Data-Driven TV Ad Targeting

OptimizeRx Corp. (Nasdaq: OPRX), a healthcare technology company, has entered a strategic partnership with Simulmedia, a U.S.-based TV and streaming advertising technology firm. The collaboration is focused on enabling pharmaceutical advertisers to deploy OptimizeRx’s Micro-Neighborhood® Targeting (MNT) data through Simulmedia’s advertising platform across linear, …

Team Kalkine | 18 June 2025

Align Technology (Nasdaq: ALGN) Launches Campaigns Targeting Orthodontic Care for Children and Teens

Align Technology, Inc. (Nasdaq: ALGN),a global medical device manufacturer specializing in digital orthodontics, has launched two coordinated campaigns aimed at promoting awareness and understanding of orthodontic solutions for children and teenagers. The new initiatives “Invisalign for Kids” targeting consumers and “Growing Patients” targeting dental …

Team Kalkine | 18 June 2025

EHang (Nasdaq: EH) Expands Battery Partnership with Gotion for eVTOL Development

EHang Holdings Limited (Nasdaq: EH), a China-based developer of autonomous aerial vehicle (AAV) technology, has announced an expansion of its strategic collaboration with Gotion High-Tech Co., Ltd., a China-based provider of battery solutions. This move builds upon an earlier power system framework agreement signed …

Team Kalkine | 18 June 2025

Dell Technologies (NYSE: DELL) Declares CAD 0.525 Dividend, Annual Payout Up 18% in 2025

Dell Technologies Inc. (NYSE: DELL)is a global provider of technology solutions, products, and services. The company operates across segments such as Infrastructure Solutions Group (ISG), Client Solutions Group (CSG), and Dell Financial Services (DFS). Its offerings include servers, storage, networking equipment, PCs, and hybrid …

Team Kalkine | 18 June 2025

Markets Navigate Middle East Tensions Ahead of Fed Decision

Index Update:U.S. stocks closed higher on Monday, with the Dow up 0.75%, the S&P 500 rising 0.94%, and the Nasdaq gaining 1.52%, as investors largely brushed off Middle East tensions. Gains were led by communication services, technology, and consumer discretionary sectors, while utilities, health …

Team Kalkine | 17 June 2025

Genflow Biosciences (LSE:GENF) Advances SIRT6 Pipeline and Aging Trials Across Multiple Programs

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF), a UK-based biotechnology company with research operations in Belgium, has provided a mid-year update on its gene therapy pipeline focused on aging and age-related diseases. The company, which holds exclusive rights to SIRT6 gene variants associated with longevity, has reported …

Team Kalkine | 17 June 2025
Support

Hi! How can we help you today?

Loading…